1. Home
  2. ENSC vs SXTC Comparison

ENSC vs SXTC Comparison

Compare ENSC & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$0.30

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Logo China SXT Pharmaceuticals Inc.

SXTC

China SXT Pharmaceuticals Inc.

N/A

Current Price

$2.42

Market Cap

1.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ENSC
SXTC
Founded
2003
2005
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
1.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
ENSC
SXTC
Price
$0.30
$2.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
947.2K
123.4K
Earning Date
05-13-2026
08-19-2019
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$55.01
N/A
Revenue Next Year
$1,033.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.03
52 Week High
$2.75
$6.98

Technical Indicators

Market Signals
Indicator
ENSC
SXTC
Relative Strength Index (RSI) 52.04 60.62
Support Level $0.23 $1.35
Resistance Level $0.32 $2.68
Average True Range (ATR) 0.02 0.28
MACD 0.01 0.04
Stochastic Oscillator 69.47 71.76

Price Performance

Historical Comparison
ENSC
SXTC

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About SXTC China SXT Pharmaceuticals Inc.

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Share on Social Networks: